This week's View explores whether post-TAVR 30-day stroke risk has declined as device technology and operator experience have improved, what the optimum SBT duration and impact of pressure support ventilation are in relation to the likelihood of extubation success and other outcomes, and if a simple risk-assessment tool can be developed for patients undergoing preoperative evaluation before noncardiac surgery.

Subscribe on iTunes | Subscribe on Google Play

Keywords: EaglesEyeView, Airway Extubation, Anemia, Angina Pectoris, Biomarkers, Carotid Stenosis, Cardiac Surgical Procedures, Dyspnea, Electrocardiography, Heart Valve Diseases, Heart Valve Prosthesis, Hemoglobins, Hypertension, Intensive Care Units, Ischemic Attack, Transient, Length of Stay, Myocardial Infarction, Noninvasive Ventilation, Peripheral Arterial Disease, Positive-Pressure Respiration, Preoperative Care, Primary Prevention, Quality Improvement, Respiration, Respiration, Artificial, Risk Assessment, Risk Factors, Risk Reduction Behavior, Secondary Prevention, Stroke, General Surgery, STS/ACC TVT Registry, Transcatheter Aortic Valve Replacement, Triage, Troponin, Vascular Diseases, Ventilator Weaning, Heart Failure, Coronary Angiography

< Back to Listings